National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

meloxicam
An oxicam derivative and a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Unlike traditional nonselective NSAIDs, meloxicam preferentially inhibits the activity of cyclo-oxygenase II (COX-II), resulting in a decreased conversion of arachidonic acid into prostaglandin precursors. The resulting decrease in prostaglandin synthesis is responsible for the therapeutic effects of meloxicam. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:Mobec
Mobic
Mobicox
Movalis
Movatec
Chemical structure name:4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide



Previous:MEK inhibitor GSK1120212, MEK inhibitor RDEA119, MEK inhibitor XL518, Melan-A VLP vaccine, melanoma helper peptide vaccine
Next:melphalan, memantine hydrochloride, menatetrenone, menogaril, Menogarol

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov